Abstract
Abstract:Diffuse malignant peritoneal mesothelioma (DMPM) represents 90% of all peritoneal forms of mesothelioma. It affects mainly patients 50–69 years old. In 50% of cases there is a history of asbestos exposure. The clinical presentation of the disease is not characteristic: nonspecific abdominal pain, weight loss, and abdominal distension are common. Ascites occurs in 90% of the patients. Bowel obstruction is a late manifestation. We present three patients with DMPM, without a history of asbestos exposure and without ascites, who presented with complete bowel obstruction. All patients underwent emergency operations, and palliative surgical procedures were performed. Each patient died within 3 to 6 months postoperatively.
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view purchase options.
Create a free account, then purchase this article to download or access it online for 24 hours.
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
References
References1. Britton M. The epidemiology of mesothelioma. Semin Oncol 2002;29:18–25.BrittonMThe epidemiology of mesothelioma.Semin Oncol20022918-252. Sebbag G, Yan H, Shmookler BM, et al. Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 2000;87:1587–1593.SebbagG]]YanH]]ShmooklerBM&etal;Results of treatment of 33 patients with peritoneal mesothelioma.Br J Surg2000871587-15933. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol 2007;18:985–990.BoffettaPEpidemiology of peritoneal mesothelioma: a review.Ann Oncol200718985-9904. Yan TD, Popa E, Brun EA, et al. Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg 2006;93:1536–1542.YanTD]]PopaE]]BrunEA&etal;Sex difference in diffuse malignant peritoneal mesothelioma.Br J Surg2006931536-15425. Bridda A, Padoan I, Mencarelli R, et al. Peritoneal mesothelioma: a review Med Gen Med 2007;9:32.BriddaA]]PadoanI]]MencarelliR&etal;Peritoneal mesothelioma: a reviewMed Gen Med20079326. Eltabbakh GH, Piver MS, Hempling RE, et al. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999;70:6–12.EltabbakhGH]]PiverMS]]HemplingRE&etal;Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma.J Surg Oncol1999706-127. Bani-Hani KE, Gharaibeh KA. Malignant peritoneal mesothelioma. J Surg Oncol 2005;91:17–25.Bani-HaniKE]]GharaibehKAMalignant peritoneal mesothelioma.J Surg Oncol20059117-258. Deraco M, Nonaka D, Baratti D, et al. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006;13:229–237.DeracoM]]NonakaD]]BarattiD&etal;Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.Ann Surg Oncol200613229-2379. Nonaka D, Kusamura S, Baratti D, et al. Diffuse malignant mesothelioma of the peritoneum: a clinicopathologic study of 35 patients treated locoregionally at a single institution. Cancer 2005;104:2181–2188.NonakaD]]KusamuraS]]BarattiD&etal;Diffuse malignant mesothelioma of the peritoneum: a clinicopathologic study of 35 patients treated locoregionally at a single institution.Cancer20051042181-218810. Cerruto CA, Brun EA, Chang D, et al. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med 2006;130:1654–1661.CerrutoCA]]BrunEA]]ChangD&etal;Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma.Arch Pathol Lab Med20061301654-166111. Asensio JA, Goldblatt P, Thomford NR. Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature. Arch Surg 1990;125:1477–1481.AsensioJA]]GoldblattP]]ThomfordNRPrimary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature.Arch Surg19901251477-148112. Yan TD, Haveric N, Carmignani CP, et al. Computed tomographic characterization of malignant peritoneal mesothelioma. Tumori 2005;91:394–400.YanTD]]HavericN]]CarmignaniCP&etal;Computed tomographic characterization of malignant peritoneal mesothelioma.Tumori200591394-40013. Levy AD, Arnáiz J, Shaw JC, et al. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics 2008;28:583–607.LevyAD]]ArnáizJ]]ShawJC&etal;From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation.Radiographics200828583-60714. Jeong YJ, Kim S, Kwak SW, et al. Neoplastic and nonneoplastic conditions of serosal membrane origin: CT findings. Radiographics 2008;28:801–818.JeongYJ]]KimS]]KwakSW&etal;Neoplastic and nonneoplastic conditions of serosal membrane origin: CT findings.Radiographics200828801-81815. Lyons-Boudreaux V, Mody DR, Zhai J, et al. Cytologic malignancy versus benignancy: how useful are the “newer” markers in body fluid cytology? Arch Pathol Lab Med 2008;132:23–28.Lyons-BoudreauxV]]ModyDR]]ZhaiJ&etal;Cytologic malignancy versus benignancy: how useful are the “newer” markers in body fluid cytology?Arch Pathol Lab Med200813223-2816. Pomjanski N, Grote HJ, Sander O, et al. Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report. Diagn Cytopathol 2008;36:120–123.PomjanskiN]]GroteHJ]]SanderO&etal;Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: a case report.Diagn Cytopathol200836120-12317. Van de Walle P, Blomme Y, Van Outryve L. Laparoscopy and primary diffuse malignant peritoneal mesothelioma: a diagnostic challenge. Acta Chir Belg 2004;104:114–117.Van de WalleP]]BlommeY]]Van OutryveLLaparoscopy and primary diffuse malignant peritoneal mesothelioma: a diagnostic challenge.Acta Chir Belg2004104114-11718. Milingos S, Protopapas A, Papadimitriou C, et al. Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool. J Minim Invasive Gynecol 2007;14:43–48.MilingosS]]ProtopapasA]]PapadimitriouC&etal;Laparoscopy in the evaluation of women with unexplained ascites: an invaluable diagnostic tool.J Minim Invasive Gynecol20071443-4819. Lee PS, Auyeung KM, King DA. Pitfalls in diagnosis of early stage malignant peritoneal mesothelioma: a case report. Clin Imaging 2002;26:263–266.LeePS]]AuyeungKM]]KingDAPitfalls in diagnosis of early stage malignant peritoneal mesothelioma: a case report.Clin Imaging200226263-26620. Elias D, Bedard V, Bouzid T, et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol 2007;31:784–788.EliasD]]BedardV]]BouzidT&etal;Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy.Gastroenterol Clin Biol200731784-78821. Deraco M, Bartlett D, Kusamura S, et al. Consencus statement on peritoneal mesothelioma. J Surg Oncol 2008;98:268–272.DeracoM]]BartlettD]]KusamuraS&etal;Consencus statement on peritoneal mesothelioma.J Surg Oncol200898268-27222. Yan TD, Welch L, Black D, et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007;18:827–834.YanTD]]WelchL]]BlackD&etal;A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma.Ann Oncol200718827-83423. Brigand C, Monneuse O, Mohamed F, et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 2006;13:405–412.BrigandC]]MonneuseO]]MohamedF&etal;Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.Ann Surg Oncol200613405-41224. Yan TD, Brun EA, Cerruto CA, et al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2007;14:41–49.YanTD]]BrunEA]]CerrutoCA&etal;Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.Ann Surg Oncol20071441-4925. Scagliotti GV, Selvaggi G. Emerging drugs for mesothelioma. Expert Opin Emerg Drugs 2007;12:127–137.ScagliottiGV]]SelvaggiGEmerging drugs for mesothelioma.Expert Opin Emerg Drugs200712127-13726. Garcia-Carbonero R, Paz-Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol 2006;32:676–681.Garcia-CarboneroR]]Paz-AresLSystemic chemotherapy in the management of malignant peritoneal mesothelioma.Eur J Surg Oncol200632676-68127. Fasola G, Puglisi F, Follador A, et al. Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report. BMC Cancer 2006;6:289.FasolaG]]PuglisiF]]FolladorA&etal;Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report.BMC Cancer20066289
